Australian Chemicals Stock News

PRL Global (ASX:PRG) Posts H1 2026 Results With Solid Revenue Base and Positive EPS PRL Global (ASX:PRG) opened its H1 2026 earnings season story with A$786.1 million in revenue and basic EPS of A$0.03, setting the tone against a backdrop of very large reported earnings growth over the last 12 months and a share price around A$1.46. The company has seen revenue move from A$628.2 million in H2 2024 to A$696.1 million in H1 2025 and then A$786.1 million in H2 2025. Basic EPS shifted from a loss...

Cromwell Property Group (ASX:CMW) has posted its H1 2026 numbers with total revenue of A$88.2 million and basic EPS of A$0.00145, giving investors a fresh datapoint on how the office focused REIT is tracking. The group has seen recent revenue move from A$97.9 million in H2 2024 to A$94.4 million in H1 2025 and then A$88.2 million in H2 2025. Basic EPS shifted from a loss of A$0.037802 per share in H2 2024 to a loss of A$0.041925 in H1 2025 and then a small profit of A$0.00145 in H2 2025. For...

Alcidion Group H1 2026 earnings: profitability resets as topline scales Alcidion Group (ASX:ALC) reported a clean headline for H1 2026, with total revenue of A$23.1 million and basic EPS of A$0.001893, and net income of A$2.5 million marking a return to profit at the half year. The company reported revenue of A$18.0 million in H2 2024, A$17.6 million in H1 2025 and A$23.1 million in H2 2025. EPS moved from a loss of A$0.00304 per share in H2 2024 to a loss of A$0.000662 in H1 2025 and then to...

If you are wondering whether Lynas Rare Earths at A$18.98 still offers value after its recent run, this article will walk through what the current price might be implying. The stock has logged returns of 21.0% over the last 7 days, 17.2% over 30 days, 55.3% year to date, 179.5% over 1 year, 143.3% over 3 years and 213.7% over 5 years, which raises fair questions about how much optimism is already in the price. Recent news around rare earths supply security, policy support for critical...

Buy-back puts Dyno Nobel (ASX:DNL) capital management in focus Dyno Nobel (ASX:DNL) is in the spotlight after continuing its on-market share buy-back, with more than 34 million ordinary shares already repurchased as part of its ongoing capital management program. See our latest analysis for Dyno Nobel. The on market buy back comes as Dyno Nobel’s share price sits at A$3.32, with a 1 month share price return of a 6.21% decline but a 1 year total shareholder return of 25.30%, indicating longer...

Macmahon Holdings (ASX:MAH) has drawn fresh attention after reporting higher half year revenue of A$1,310.53 million, increased net income of A$48.21 million, a higher interim dividend, and reaffirmed its FY26 earnings guidance. See our latest analysis for Macmahon Holdings. While the latest results and higher interim dividend have caught investors’ attention, Macmahon’s 30 day share price return of 7.19% and 90 day share price return of 28.45% build on very large 1 year and 3 year total...

Waypoint REIT (ASX:WPR) has put fresh numbers on the table for FY 2025, with first half revenue of A$178.3 million and basic EPS of A$0.20, setting the tone for how investors assess the latest period. The trust has seen revenue move from A$118.2 million and EPS of A$0.14 in the first half of 2024 to A$178.3 million and EPS of A$0.20 in the first half of 2025. The trailing twelve month EPS sits at A$0.30 on revenue of A$162.8 million for the most recent half, giving investors a fuller view of...

NOVONIX FY 2025 earnings snapshot NOVONIX (ASX:NVX) opened FY 2025 with first half revenue of about US$2.8 million and a basic EPS loss of US$0.03, while net income excluding extras came in at a loss of roughly US$20.1 million. Over recent periods the company has seen revenue move from about US$2.7 million in 1H FY 2024 to US$3.1 million in 2H FY 2024 and back to US$2.8 million in 1H FY 2025. EPS losses have ranged between US$0.06 and US$0.09 before the latest US$0.03 result. The market will...

Actinogen Medical (ASX:ACW) has reported its H1 2026 numbers with trailing twelve month revenue of A$7.4 million and a basic EPS loss of A$0.0058 per share, keeping the focus firmly on how much cash the business is consuming rather than generating. The company has seen reported half year revenue move between A$9.0 million in H2 2024, A$0 in H1 2025 and A$5.5 million in H2 2025, alongside basic EPS losses of A$0.0007, A$0.0028 and A$0.0022 respectively, so investors are likely to be weighing...

COG Financial Services (ASX:COG) has put fresh numbers on the table for H1 2026, with trailing 12 month revenue of A$383.5 million, net income of A$20.2 million and basic EPS of A$0.099, set against a share price of A$1.54. The company has seen revenue move from A$367.7 million to A$383.5 million over recent trailing 12 month periods, while basic EPS shifted from A$0.094 to A$0.099 across the same TTM snapshots. This sets up a results season where margins and earnings quality are front and...

RAM Essential Services Property Fund (ASX:REP) has just posted its H1 2026 scorecard, with trailing twelve month revenue at A$58.0 million and net income of A$4.8 million, while Funds From Operations sits at A$24.5 million, giving investors a clear read on its cash generation profile. The fund has seen revenue move from A$40.3 million in H2 2024 to A$41.0 million in H2 2025 on a half year basis, as FFO shifted from A$22.8 million to A$16.9 million over the same periods, setting up a picture...

Mader Group (ASX:MAD) has drawn attention after reporting strong 1H FY26 results and reaffirming guidance for at least A$1b in revenue and A$65m NPAT, while suspending its interim dividend to prioritise balance sheet strength and future growth. See our latest analysis for Mader Group. Despite a sharp share price pullback immediately after the dividend suspension, Mader Group’s recent 1-month share price return of 3.61% and year to date share price return of 10.77% sit alongside a very strong...

Bapcor (ASX:BAP) has reported a challenging H1 2026, with revenue of A$973.0 million and a basic EPS loss of A$0.31 tied to net income of A$104.8 million in the red. Over the last three reported halves, revenue has moved from A$1,012.4 million in H1 2025 to A$963.4 million in H2 2025 and A$973.0 million in H1 2026. Over the same periods, EPS shifted from a profit of A$0.11 in H1 2025 to a loss of A$0.04 in H2 2025 and a deeper loss of A$0.31 in the latest half. This sets up a results season...

Capral (ASX:CAA) has kicked off FY 2025 with first half revenue of A$327.2 million and basic EPS of A$0.91, while trailing 12 month EPS sits at A$2.15 on revenue of A$694.3 million. This is setting a clear earnings season benchmark for investors watching the aluminium products space. Over recent periods the company has seen revenue move from A$313.4 million and EPS of A$0.84 in 1H FY 2024, to A$291.0 million and EPS of A$1.04 in 2H FY 2024, and then to the latest A$327.2 million and EPS of...

Earnings jump and dividend reset put focus on Perpetual’s trade offs Perpetual (ASX:PPT) has drawn fresh attention after reporting half year sales of A$704.1 million and net income of A$53.9 million, alongside a lower ordinary dividend of A$0.59 per share. The result, which also included higher basic and diluted earnings per share from continuing operations compared with a year earlier, sits alongside an announced ordinary unfranked dividend payable on 7 April 2026, with a March ex date and...

Technology One (ASX:TNE) has lifted its FY26 profit before tax growth guidance to 18% to 20% and raised recurring revenue growth targets to 16% to 18%, citing confidence in its SaaS+ pipeline. See our latest analysis for Technology One. That upgraded FY26 guidance comes as Technology One’s share price has risen 4.57% over the last day and 5.33% over the past week. The 90 day share price return of 13.39% and 1 year total shareholder return of a 10.49% decline highlight that recent momentum is...

29Metals (ASX:29M) has kicked off FY 2025 with first half revenue of A$271.0 million and basic EPS of A$0.026, with trailing twelve month revenue at A$566.6 million and EPS at A$0.018 as the business shifts back into profit on a full year basis. Over the past year, the company has seen revenue move from A$551.1 million to A$566.6 million on a trailing basis, while net income has turned from a A$177.6 million loss to a A$24.2 million profit. This signals a clear reset in earnings power and...

Objective (ASX:OCL) has reported its H1 2026 results with trailing 12 month revenue of A$128.9 million and basic EPS of A$0.388672, set against a year where earnings growth was 16.2%. The company has seen half year revenue move from A$59.7 million in H2 2024 to A$61.3 million in H1 2025 and A$62.2 million in H2 2025, while basic EPS has tracked A$0.157122, A$0.179 and A$0.192675 across those periods. These figures set up the latest numbers in the context of steadily expanding net profit...

MotorCycle Holdings (ASX:MTO) has put fresh numbers on the board for H1 2026, with trailing twelve month revenue at A$718.8 million and net income of A$19.8 million setting the backdrop for its latest earnings update. The company has seen revenue move from A$616.7 million to A$650.4 million and then to A$718.8 million over the past three reported trailing periods, while basic EPS over the last full year in the data sits in the mid 20 cent range. With net profit margins holding steady at 2.8%,...

Appen (ASX:APX) has put fresh numbers on the table, pairing its 2025 full year result with a new 2026 revenue outlook of US$270 million to US$300 million, giving investors updated earnings context. See our latest analysis for Appen. The new guidance appears to have landed in the middle of a sharp re‑rating, with Appen’s 30 day share price return of 72.69% and 90 day share price return of 160.84% contrasting with a 5 year total shareholder return decline of 86.48%. This suggests recent...

Clinuvel Pharmaceuticals (ASX:CUV) has put out its H1 2026 scorecard with investors looking closely at the recent revenue and EPS trends relative to its trailing performance. The company has seen total revenue move from A$55.4 million in H2 2024 to A$59.4 million in H2 2025, while basic EPS shifted from A$0.49 to A$0.44 over the same halves. This sets the backdrop for trailing 12 month figures that include revenue of A$96.9 million and basic EPS of A$0.65. With trailing net profit margins...

Betr Entertainment (ASX:BBT) has reported H1 2026 revenue of A$68.9 million with a net loss of A$32.7 million, equal to basic EPS of A$0.031, setting a clear earnings season marker for investors watching the betting and entertainment space. The company has seen first half revenue move from A$27.8 million in 2024 to A$68.9 million in 2025, while basic EPS shifted from A$0.0517 to A$0.031 and net loss widened from A$10.4 million to A$32.7 million over the same halves. The latest numbers are...

Bhagwan Marine (ASX:BWN) H1 2026 Earnings Snapshot Bhagwan Marine (ASX:BWN) has reported its H1 2026 numbers with trailing 12 month revenue of A$245.8 million and basic EPS of A$0.0239, setting the tone for how investors assess the latest half against its recent track record. The company has seen revenue move from A$159.4 million in H2 2024 to A$154.1 million in H1 2025 and A$128.9 million in H2 2025, while basic EPS shifted from A$0.0078 to A$0.0339 and then A$0.0133 over those same periods,...

CSL (ASX:CSL) has come into focus after out licensing its IL 6 antibody clazakizumab to Eli Lilly, securing A$100 million up front, along with future milestones and royalties tied to Lilly led development. See our latest analysis for CSL. That clazakizumab deal lands at a time when CSL’s share price has been under pressure, with a 30 day share price return showing an 18.55% decline, a 90 day share price return showing a 21.22% decline and a 1 year total shareholder return showing a 42.56%...